Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-07
1999-10-26
Chan, Christina Y.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435366, 435372, C12N 508
Patent
active
059726270
ABSTRACT:
The invention relates to methods of enriching for hematopoietic cell populations enriched in myeloid and/or lymphoid progenitor cells based on cell specific markers. The methods also provide an enriched population of prethymic lymphoid-committed progenitor population lacking long-term hematopoietic reconstitution potential. Compositions enriched for the cells and populations of cells obtained therefrom are also provided by the invention. Methods of use of the cells are also included. Methods of genetically modifying the cells are provided as are cells obtained thereby.
REFERENCES:
patent: 4714680 (1987-12-01), Civin
patent: 5061620 (1991-10-01), Tsukamoto et al.
patent: 5147784 (1992-09-01), Peault
patent: 5359046 (1994-10-01), Capon et al.
patent: 5409825 (1995-04-01), Hoffman et al.
patent: 5605829 (1997-02-01), McGlave et al.
Bloom, "A Perspective of AIDS Vaccines" Science (1996) 272:1888-1890.
Mayani et al. "Cytokine-Induced Selective Expansion and Maturation of Erythroid Versus Myeloid Progenitors from Purified Cord Blood Precursor Cells" Blood (1993)81(12):3252-3258.
Mayani et al. "Characterization of Functionally distinct Subpopulations of CD34.sup.+ Cord Blood Cells in Serum-Free Long-Term Cultures Supplemented with Hematopoietic Cytokines" Blood (1993) 82(9):2664-2672.
Schmidt et al. "Expression of CD34 on human B cell precursors" Clin. Exp. Immunol. (1991)85:168-173.
Bender et al., "Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood and mobilized peripheral blood from patients undergoing autologous stem cell transplantation" Clinical Immunology and Immunopathology (1994) 70:10-18.
Galy et al., "Human T, B, Natural Killer and Dendritic Cells arise from a common bone marrow progenitor cell subset" Immunity(1995) 3:459-473.
Bernstein et al. "Recombinant human stem cell factor enhances the formation of colonies by CD34.sup.+ and CD34.sup.+ lin- cells, and the generation of colony-stimulating progeny from CD34.sup.+ lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony stimulating factor" Blood (1991) 77:2316-2321.
Gross et al., "Endowing T cells with antibody specificity using chimeric T cell receptors" FASEB J. (1992) 6:3370-3378.
Nienhuis et al. "Gene transfer into hematopoietic stem cells" Cancer (1991)67(10):2700-2704.
Beutler et al. "Gene transfer in the treatment of hematologic disease" Experimental Hematology (1990) 18:857-860.
Johnston et al. "Present status and future prospects for HIV therapies" Science (1993) 260:1286-1293.
Mulligan et al. "The basic science of gene therapy" Science (1993) 260:926-931.
Culver et al. "Lymphocyte gene therapy" Human Gene Therapy (1991)2:107-109.
Roemer et al. "Concepts and stratgies for human gene therapy" European J. Biochem. (1992) 208:211-225.
Fields et al., Fundamental Virology (1991) Raven Press, Ltd., New York, pp. 267-290 and 709-723.
Paul et al., "Stromal cell-associated hematopoiesis: Immortalization and characterization of a primate bone marrow-derived stromal cell line" Blood (1991) 77:1723-1733.
Fletcher et al., "Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors" Blood (1990) 76:1098-1103.
Metcalf et al., "Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice" Blood (1990) 76:50-56.
Verfaillie et al., "Leukemia inhibitory factor/human interleukin for DA cells: a growth factor that stimulates the in vitro development of multipotential human hematopoietic progenitors" Blood (1991) 77:263-270.
Dick et al., "Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays" Blood (1991) 78:624-634.
Smith et al., "Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides" Nature (1988) 336:688-690.
Whitlock et al., "Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule" Cell (1987) 48:1009-1021.
Williams et al., "Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells" Nature (1988) 336:684-687.
Nichols et al., "Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity" Development (1990) 110:1341-1348.
Metcalf, "The leukemia inhibitory factor (LIF)" Intl. J. Cell. Clon. (1991) 9:95-108.
Leary et al., "Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells" Blood (1990) 75:1960-1964.
Beaucage et al., "Deoxynucleoside phosphoramidites--a new class of key intermediates for deoxypolynucleotide synthesis" Tetra. Let. (1981) 22:1859-1862.
Matteucci et al., "Synthesis of deoxyoligonucleotides on a polymer support" J. Amer. Chem. Soc. (1981) 103:3185-3191.
Metzger et al., "The human oestrogen receptor functions in yeast" Nature (1988) 334:31-36.
Spangrude, "Enrichment of murine haemopoietic stem cells: diverging roads" Immunol. Today (1989) 10:344-350.
Andrews et al., "The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors" Blood (1986) 68:1030-1035.
Miller et al., "Improved retroviral vectors for gene transfer and expression" BioTechniques (1989) 7:980-990.
van Beusechem et al., "Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses" J. Exp. Med. (1990) 172:729-736.
Valerio et al., "Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat" Gene (1989) 84:419-427.
Parks et al., "Fluorescence-activated cell sorting: theory, experimental optimization, and applications in lymphoid cell biology" Meth. Enzymol. (1984) 108:197-241.
Dalchau et al., "Identification and unusual tissue distribution of the canine and human homologues of THY-1 (P)" J. Exp. Med. (1979) 149:576-591.
Bender et al., "Expression of the human .beta.-globin gene after retroviral transfer into murine erythroleukemia cells and human BFU-E cells" Mol. Cell. Biol. (1988) 8:1725-1735.
Moreau et al., "Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells" Nature (1988) 336:690-692.
Jorgensen et al., "Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics" Nature (1992) 355:224-230.
Freshney, Culture of Animal Cells--A Manual of Basic Technique (1988) Alan R. Liss, Inc., New York, pp. 60-61, and 139-140.
Fletcher et al., "Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo" J. Exp. Med. (1991) 174:837-845.
Bodine et al., "Effects of hematopoietic growth factors on the survival of primitive stem cells in liquid suspension culture" Blood (1991) 78:914-920.
Metcalf, "The induction and inhibition of differentiation in normal and leukaemic cells" Phil. Trans. R. Soc. Lond. (1990) B327:99-109.
Mathe, ed., "Tactics and strategy in cancer treatment" Recent Results in Cancer Research, Springer-Verlag, Berlin, pp. 1-227. The title page and table of contents were originally submitted, 1977.
Caux et al., "GM-CSF and TNF-.alpha. cooperate in the generation of dendritic Langerhans cells" Nature (1992) 360:258-261.
Karlsson, "Treatment of genetic defects in hematopoietic cell function by gene transfer" Blood (1991) 78(10):2481-2492.
Cairo et al., "The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34.sup.+ cord blood" Pediatric Res. (1992) 32(3):277-281.
O'Doherty et al., "Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium" J. Exp. Med. (1993) 178:1067-1078.
Gore et al., "Normal human bone marrow precursors that express terminal deoxynucleotidyl
Chan Christina Y.
Rabin Evelyn
Shaw Melissa A.
Systemix, Inc.
LandOfFree
Method of purifying a population of cells enriched for dendritic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of purifying a population of cells enriched for dendritic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of purifying a population of cells enriched for dendritic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-762363